Enabling biology at the edge.

ANTA is an early-stage biotech start-up

that’s pushing the boundaries of science.

OUR NAME

Anta (अन्त) is a Sanskrit word meaning "edge," "frontier," "boundary," and "limit."

Throughout history, edges have been places of discovery. In ancient Sanskrit texts, grāmānte (“gram” + “anta” = “grāmānte”)—"at the edge of the village"—described the boundary between the familiar and the unknown, where explorers took their first steps into uncharted territory.

At ANTA, we bring biology to the edge.
The edge of innovation, where automated technology makes the impossible routine.
The edge of extreme environments, from polar ice to deep ocean.
The edge of space, where the International Space Station orbits.

Wherever science needs to go, we make it possible.

OUR PHILOSOPHY

Edge (anta) is not a limitation—it's an invitation.
The edge is where discovery happens.
The edge is where innovation is required.
The edge is where the future is built.

We don't just operate at the edge. We are the edge.

At ANTA, our mission is to develop automated sample prep platforms that operate anywhere— from remote field sites on Earth to space stations in low Earth orbit.

Our WRKR-B platform performs sample prep in any environment, enabling on-demand genomics at the edge of human exploration.

Traditional biology is confined to the lab. We bring the lab to the edge.

We develop technologies that thrive where traditional tools fail—whether on an orbiting spacecraft, a remote location, in the field, outside the traditional lab, and other austere environments. Our innovations in sequencing biochemistry and device design are reshaping how and where biology can be done.

Why it matters.

When space scientists need to sequence DNA on the ISS (or near-future commercial space stations), they need sample prep at the edge.

When the military deploys to remote locations, they need diagnostics at the edge.

When researchers study extremophiles in Antarctica or the deep ocean, they need tools that work at the edge.

When farmers need to monitor their crop and livestock health, they need reliable easy-to-use tools at the edge.

When future missions explore Mars or the Moon, they'll need biology at the edge.

When scientists need to speed up drug discovery, they can save time by automating routine biosample prep at their lab bench.

We are building the infrastructure for biology beyond boundaries.

Meet the team

ANTA Biotech was founded by scientists and engineers driven by the need for an automated solution. Meet our team of founders, scientists, engineers, and advisors. It takes a global village to bring ideas to life.

Anjali Gupta, PhD MBA
Founder & CEO

Noorsher Ahmed, PhD
Co-founder & Advisor

Cassandra Juran, PhD
Co-founder & Advisor

Gene Yeo, PhD MBA
Co-founder & Advisor

Madeline Phelps, BSE
Engineer

Dave Laygo, BSE
Engineer

Analyne Schroeder, PhD
Scientist

John Shoffner
Advisor

Megan Sieffert
Advisor

Chris Mason, PhD
Advisor

Joydeep Goswami, PhD
Former Advisor

Your questions,
answered

What is “biology at the edge”?

We have coined the phrase “biology at the edge” to define biological tools that enable immediate and on-demand functionality — like edge compute. Biology at the edge is a union of research and biotechnology at the extreme boundaries of operational environments and technological capabilities. Biology at the edge encompasses advancing scientific understanding in previously inaccessible research domains.

For ANTA, "the edge" has five interconnected meanings:
THE CUTTING EDGE Automated. Miniaturized. Gravity-agnostic. State-of-the-art technology that redefines what's possible.

EDGE COMPUTING Decentralized biological data processing. Analysis at the point of collection, not back in the lab. We ship data, not samples.

THE TACTICAL EDGE
Far-forward deployment. Remote operating bases. Field laboratories. Underserved communities. Where traditional labs can't go, we operate.

THE EDGE OF HABITABILITY
Extreme environments. Deserts. Polar regions. Deep ocean.
At the limits of Earth's livable zones, we enable science.

THE EDGE OF EXPLORATION
Space. The International Space Station. Lunar bases. Mars missions.

We bring biology to the frontier.

Why Space?

Space is a unique environment. Decades of research has shown that the conditions of Space, especially weightlessness (commonly known as microgravity), alter gene expression. There is much to be explored and learned. But, the right tools are not available to do this in Space. Developing gravity-agnostic tools will open up the final frontier to a new era of research and discovery. We firmly believe that solving for Space also solves many problems for Earth.

What future-proofed lab tool are you building first?

Engineering gravity-agnostic lab instruments where the same device can function both on Earth and in Space is a “white space problem”. Our first “zero to one” technology aims to automate biosample prep upstream of sequencing.

News

BioLabs San Diego Residency.

01 Oct 2025 ANTA Biotech begins residency at BioLabs, San Diego’s premier start-up lab facilities, to continue developing its proprietary technology.
NASA I-Corps.

30 Sep 2025 ANTA Biotech accepted into the Innovation Corps program to conduct customer discovery work.
NASA SBIR Phase I.

29 Sep 2025 ANTA Biotech awarded a NASA Phase I SBIR to conduct proof of concept work on biotechnology for biosample prep in a simulated gravity environment.
NSF SBIR Phase II.

15 Sep 2025 ANTA Biotech awarded Phase II SBIR by National Science Foundation to develop sample prep technology for spaceflight.
Space-H Accelerator.

10 Sep 2024 ANTA Biotech (formerly known as ANYg Labs Inc.) is pleased to be selected to participate in the Starburst accelerator for Space-Health . This program, in partnership with NASA, TRISH, Microsoft, The Methuselah Foundation, and Starburst, aims to establish a health ecosystem in space by supporting novel ideas and innovative entrepreneurs.
JLabs Residency.

3 Sep 2024 ANTA Biotech (formerly known as ANYg Labs Inc.) is now a resident company of Johnson & Johnson Innovation - JLABS , a premier life science incubator program. JLABS is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-enhancing health and wellness solutions to patients around the world. As a leader in innovation, JLABS helps entrepreneurs in pharmaceutical, medical device, consumer, and health tech bring healthcare solutions to patients and consumers. Acceptance into the JLabs life science incubator program is a competitive and selective process. Anta is proud to be part of this premier group.
NSF National I-Corps.

10 May 2024 ANTA Biotech (formerly known as ANYg Labs Inc.) was selected to participate in the NSF National I-Corp Program. This prestigious and competitive program provides funding for important customer discovery work based on Steve Blank’s business model canvas. The Anta team conducted hundreds of interviews with potential users and customers. Anta was selected by vote for the “People’s Choice Award” in this cohort program.
NSF SBIR Phase I.

15 March 2024 ANTA Biotech (formerly known as ANYg Labs Inc.), an early-stage biotech start-up, was selected for a Phase I SBIR award by the NSF [National Science Foundation] to develop an autonomous system for sample prep in space and austere environments. NSF SBIR awards are highly competitive with less than 10% of applicants selected for funding in any typical funding cycle. Anta Biotech was selected on the first attempt.
Berkeley Skydeck Pad 13.

14 October 2023 ANTA Biotech (formerly known as ANYg Labs Inc.) was accepted into the Berkeley SkyDeck Pad-13 Incubator program. This highly competitive program accepts less than 2% of applicants and provides access to carefully curated professional programming, experienced advisors with entrepreneurial experience, and resources relevant to and coveted by start-up enterprises.